CareCloud (CCLD) vs Exascale Labs (XLAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CareCloud (CCLD) has outperformed Exascale Labs (XLAB) over the past year, losing 31.3% versus a loss of 86.7%. CareCloud is the larger company by market cap ($85.9 million vs $85.6 million), about 1.0 times the size, while Exascale Labs is growing revenue faster (+111.3% vs +8.7%). CareCloud converts more of its revenue into profit, with a net margin of 9.0% versus -82.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CCLD | XLAB |
|---|---|---|
| Share price | $2.02 | $1.33 |
| Market cap | $85.95M | $85.57M |
| 1-day change | -12.93% | -10.74% |
| YTD return | -30.82% | -86.74% |
| 1-year return | -31.29% | -86.74% |
| 5-year return | -70.77% | — |
| P/E ratio (TTM) | 16.83 | — |
| Forward P/E | 4.49 | — |
| EPS (TTM) | $0.12 | $-0.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $120.50M | $14.82M |
| Revenue growth (YoY) | +8.72% | +111.29% |
| Net income (latest FY) | $10.80M | $-12.16M |
| Gross margin | — | 16.31% |
| Operating margin | 9.41% | -32.39% |
| Net margin | 8.96% | -82.05% |
| 52-week high | $3.81 | $11.17 |
| 52-week low | $1.67 | $0.778 |
| Distance from 52-week high | -46.98% | -88.09% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +262.87% | — |
| Average volume | 419.26K | 7.10M |
| Shares outstanding | 42.55M | 33.69M |
| Employees | 3,650 | — |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CCLD has outperformed XLAB by 55.4 percentage points over the past year.
- CareCloud is more profitable, keeping 9.0 cents of every revenue dollar as net income versus -82.1 cents for Exascale Labs.
- Exascale Labs grew revenue faster in its latest fiscal year (+111.29% vs +8.72%).
About CareCloud
CCLD stock →CareCloud, Inc., a healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States. It operates through Healthcare IT and Medical Practice Management segments.
Technology · Computer Software: Prepackaged Software · 3,650 employees
About Exascale Labs
XLAB stock →Exascale Labs Holdings Inc. develops and operates AI computer infrastructure platforms.
Technology · Computer Software: Prepackaged Software
CCLD vs XLAB FAQ
Which is bigger, CareCloud or Exascale Labs?
CareCloud (CCLD) is larger, with a market capitalization of $85.95M compared with $85.57M for Exascale Labs (XLAB).
Which stock has performed better over the past year, CCLD or XLAB?
CCLD returned -31.29% over the past 12 months, compared with -86.74% for XLAB (price return, excluding dividends). Past performance does not predict future results.
Are CareCloud and Exascale Labs in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.